Journals / MN Oftalmoloji / 2014 / Cilt: 21 - Sayı: 3

Acute vision loss after ıntravitreal triamcinolone acetonide ınjection due to trapped ıntralenticular drug particles

İntravitreal triamsinolon asetonid enjeksiyonu sonrası lens içerisinde hapsolmuş ilaç partiküllerine bağlı gelişen akut görme kaybı

Pages
215–217
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Intravitreal TA may be trapped in the lens if the needle does not inserted centrally and this may cause acute decrease in vision even the day after the injection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Seventy-one year-old diabetic patient presented with sudden vision loss after the triamci- nolone acetonide (TA) injection for the treatment of clinically significant macular edema.
📊
Key Findings & Data:Patient’s visual acuity was finger counts at 2 meters after the injection.
💡
Conclusion & Impact:Intravitreal TA may be trapped in the lens if the needle does not inserted centrally and this may cause acute decrease in vision even the day after the injection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Seventy-one year-old diabetic patient presented with sudden vision loss after the triamci- nolone acetonide (TA) injection for the treatment of clinically significant macular edema. Patient’s visual acuity was finger counts at 2 meters after the injection. Slit-lamp examination showed intralenticular trapment of TA particle and fine needle tract in the lens. Phacoemulsification and intraocular lens implantation performed. Intravitreal TA may be trapped in the lens if the needle does not inserted centrally and this may cause acute decrease in vision even the day after the injection.

Özet

Yetmişbir yaşında diyabetik olgu klinik olarak anlamlı maküla ödemi tedavisi nedeniyle ya- pılan intravitreal triamsinolon asetat (TA) enjeksiyonu sonrası ani görme kaybı ile başvurdu. Hastanın enjeksiyon sonrası görme keskinliği 2 metreden parmak sayma düzeyindeydi. Biyomikroskopik muayenesinde intralentiküler TA partikülleri ve lens üzerinde iğne giriş izi iz- lendi. Fakoemülsifikasyon ve intraoküler lens implantasyonu uygulandı. İntravitreal TA enjeksiyonu sonrası iğne merkeze doğru yönlendirilmediyse TA lens içeri- sinde birikebilir ve bu durum enjeksiyondan hemen sonra akut görme azalmasına neden ola- bilir.

🔖

Cite This Article

YALÇIN, N. G., AKTAŞ, Z., HASANREİSOĞLU, C. M., ÖZDEK, Ş. (2014). Acute vision loss after ıntravitreal triamcinolone acetonide ınjection due to trapped ıntralenticular drug particles. MN Oftalmoloji, Cilt: 21 - Sayı: 3, 215–217. https://ajindex.com/articles/295693

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Cunningham MA, Edelman JL, Kaushal S. Intravitreal steroids for macular edema: The past, the present, and the future. Surv Ophthalmol 2008;53:139-49
  2. Jager RD, Aiello LP, Patel SC, Cunningham Jr ET. Risks of in- travitreous injection: a comprehensive review. Retina 2004; 24:676-98
  3. Meyer CH, Rodrigues EB, Michels S, Mennel S, Schmidt JC, Helb HM, et al. Incidence of Damage to the Crystalline Lens During Intravitreal Injections. J Ocul Pharmacol Ther 2010; 26:491-5
  4. Degenring RF, Sauder G. Vitreous prolapse and IOL disloca- tion during intravitreal injection of triamcinolone ace- tonide. Graefes Arch Clin Exp Ophthalmol 2006; 244:1043-4
  5. Brown DM, Kaiser PK, Heier JS, Sy JP, Ianchulev T; Anchor Study Group. Ranibizumab versus verteporfin neovascular age-related macular degeneration. N Eng J Med 2006;355: 1432-44
  6. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK and Chung CY, et al; Marina Study Group. Ranibizumab for neo- vascular age-related macular degeneration. N Eng J Med 2006;355:1419-31
  7. Ascaso FJ, de Gopegui ER, Cascante JM. Neodymium: yt- trium-aluminum-garnet laser anterior hyaloidotomy to treat trapped triamcinolone acetonide behind the crystalline lens after intravitreal injection. Middle East Afr J Ophthalmol 2012; 19:163-5
  8. Ramakrishnan T, Michalova K, Hall AJH. Sudden vision loss after intravitreal triamcinolone. Retinal Cases & Brief Reports 2012;6:85-6
  9. Aiello LP, Brucker AJ, Chang S, Cunningham ET Jr, D'Amico DJ, Flynn HW Jr, et al. Evolving guidelines for intravitreous in- jections. Retina 2004;24:3.